Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation.

Hiroko Kato-HayashiTakashi NiwaKoichi OhataSaki HaradaTakuro MatsumotoJunichi KitagawaHisashi TsurumiAkio Suzuki

Published in: Journal of clinical pharmacy and therapeutics (2019)

Our findings suggest that administration of teicoplanin may lead to early attainment of the effective concentration with a lower rate of clinical failure and incidence of nephrotoxicity compared to vancomycin in febrile neutropenic patients receiving HSCT.

Keyphrases

methicillin resistant staphylococcus aureus
urinary tract infection
chemotherapy induced
risk factors
acute myeloid leukemia
staphylococcus aureus
hematopoietic stem cell